Anti-inflammatory and analgesic activities of ethanol extract of Indigofera trita linn

Pharmacologyonline

Volumn 1, Issue , 2009, Pages 278-289

  Senthil Kumar, R ^a   Rajkapoor, B ^b   Perumal, P ^c   Dhanasekaran, T ^a   Alvin Jose, M ^a   Jothimanivannan, C ^a  

^a SWAMY VIVEKANANDHA COLLEGE OF PHARMACY   (India)

^b Kumarswamy Layout   (India)

^c JKK Natarajah College of Pharmacy   (India)

Author keywords

Analgesic; Anti inflammatory; Indigofera trita; Total flavonoids content; Total phenol content

Indexed keywords

ACECLOFENAC; ALCOHOL; ANALGESIC AGENT; ANTIINFLAMMATORY AGENT; FLAVONOID; INDIGOFERA TRITA EXTRACT; PENTAZOCINE; PHENOL; PLANT EXTRACT; UNCLASSIFIED DRUG;

ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG SCREENING; GRANULOMA; HOT PLATE TEST; INDIGOFERA; INDIGOFERA TRITA; MALE; NONHUMAN; PAW EDEMA; RAT; WRITHING TEST;

EID: 65549137003     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Brekhmann II, Dardimov IV. New substances of plant origin which increase nonspecific resistance. Annu. Rev. Pharmacol. 1969; 21: 219-226.
2. Patwardhan B, Hopper B. Ayurvedic and future drug development. J. Alter. Complement Med. 1992; 19:9-10.
3. Mantri P, Witiak DT. Inhibition of cyclooxygenase and 5-lipoxygenase. Curr. Med. Chem. 1994; 1: 328-355.
4. Smith WL, De Witt DL. Biochemistry of prostaglandins endoperoxide H synthase-2 and their differential susceptibility to NSAIDs. Sem. Nephrol. 1995; 15: 179-194.
5. Lipsky P. The clinical potential of COX-2 specific inhibitors. Amer. J. Med. 1999; 106: 51S-57S.
6. Farnsworth NR. Screening plants for new medicines. In: Biodiversity Part II, Wilson E O, Eds. National Academy Press, Washington, 1989: 83-97.
7. Eisner T. Chemical prospecting. A call for action. In: Ecology, Economic and Ethics, Borman FH, Kellert SR, eds. The broken cycle. Yale University Press, New Haven CT.
8. Nadkarni A K. In: Indian Materia Medica, Popular Prakashan Pvt Ltd, Bombay, Vol I, 1996: 683.
9. Kirtikar KR Basu BD. Indian Medicinal Plants, Vol I, 2nd Edn., International book publisher, Dehradun, 1993: 715-716.
10. Raju Senthil Kumar, Balasundaram Jayakar, Balasubramanian Rajkapoor. Antitumor activity of Indigofera trita on Ehrlich ascites carcinoma induced mice. Intl J Cancer Res. 2007; 3(4): 180-185.
11. 4 induced hepatotoxicity in rats. J Pharmacol Toxicol, 2008; 3(5):344-350.
12. Wagner H, Bladt S, Zgainski EM. Plant Drug Analysis, Springer - Verlag, Berlin, 1984: 298-334.
13. Winter CA, Risely EA, Nuss GW. Carrageenin-induced edema in hind paw of rats an assay for anti-inflammatory drugs. Proc. Soc. Exp. Biol. 1962; 3: 544-547.
14. D' Arcy PD, Howard EM, Muggleton PW, Jowsend SB. The anti-inflammatory action of griseofulvin in experimental animals. J. Pharmacol. 1960; 12: 659-665.
15. Koster R, Anderson N, Beer EJ. Acetic acid for analgesic screening. Federation proceeds. 1959; 18: 412-416.
16. Eddy NB, Leimbach DJ. Synthetic analgesic dithienyl butanyl and dithinyl butylamines. J. Pharmacol. Exptl. Therap. 1953; 107: 385-393.
17. Mc Doald S, Prenzler PD, Antolovich M, Robards K. Phenolic content and Antioxidnat activity of Olive extract, Food Chemistry, 2001; 73: 73-84.
18. Chia-Chi Chang, Ming-Hua Yang, Hwei-Mei Wen, Jiing-Chuan Chern. Estimation of total flavonoid content in Propolis by two complementary colorimetric methods. Journal of Food and Drug analysis, 2002; 10(3): 178-182.
19. Brito ARMS, Antonio MA. Oral anti-inflammatory and antiulcerogenic activities of a hydroalcoholic extract and partitioned fractions of Turnera ulmifolia (Turneraceae). J Ethnopharmacol. 1998; 61: 215-228.
20. Olajide OA, Awe SO, Makinde JM. Effect of the aqueous extract of Bridelia ferruginea stem bark on Carrageenan-induced edema and granuloma tissue formation in rats and mice. J Ethnopharmacol. 1999; 66: 113-117.
21. Ueno A, Naraba H, Ikeda Y, et al. Intrinsic prostacyclin contributes to exudation induced by bradykinin or Carrageenan: a study on the paw edema-induced in ipreceptor-deficient mice. Life Science 2000; 66: 155-160.
22. Nantel F, Denis D, Gordon R, et al. Distribution and regulation of cyclooxygenase-2 in carrageenan-induced inflammation. Braz. J. Pharmacol. 1999; 128: 853-859.
23. Olajide OA, Awe SO, Makinde JM, et al. Studies on the anti-inflammatory, antipyretic and analgesic properties of the Aistonia boonei stem bark. J. Ethnopharmacol. 2000; 71: 179-186.
24. Ferreira SH, Lorenzetti BB, Castro MSA, Correa FMA. Antialgic effect of Aspirin-like drugs and the inhibition of prostaglandin synthesis. In: Dumonde DC, Jasani MK eds. The recognition of anti-rheumatic drugs. MTP Press Limited, St. Leonard House, Lancaster, 1978: 25-37.
25. Deraedt R, Jouquey S, Delevallee F, Flahaut M. Release of prostaglandins E and F in an algogenic reaction and its inhibition. Eur. J. Pharmacol. 1980; 61: 17-24.
26. Hokanson GC. Acetic acid for analgesic screening. J. Nat. Prod. 1978; 41: 497-498.
27. Duarte JDG, Nakamura M, Ferreira S.H. Participation of the sympathetic system in acetic acid induced writhing in mice. Braz. J. Med. Biol. Res. 1988; 21: 341-343.
28. Ferrandiz ML, Nair AG, Alcaraz MJ. Inhibition of sheep platelet arachidonate metabolism by flavonoids from Spanish and Indian medicinal herbs. Pharmazie 1990; 45: 206-208.
29. Ferrandiz ML, Alcaraz MJ. Anti-inflammatory activity and inhibition of arachidonic acid metabolism by flavonoids. Agents Actions 1991; 32: 283-288.
30. Laughton MJ, Evans PJ, Moroney MA, Hoult JR, Halliwell B. Inhibition of mammalian 5-lipoxygenase and cyclooxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem. Pharmacol. 1991; 42: 1673-1681.
31. Robak J, Gryglewski RJ. Bioactivity of flavonoids. Pol. J. Pharmacol. 1996; 48: 555-564.
32. Kim HP, Mani I, Iversen L, Ziboh VA. Effects of naturally occurring flavonoids and bioflavonoids on epidermal cyclooxygenase and lipoxigenase from guinea pigs. Prostaglandins Leukot. Essent. Fatty Acids, 1998; 58: 17-24.
33. Damas J, Bourdon V, Remacle-Volon G, Lecomte J. Pro-antiinflammatory flavonoids which are inhibitors of prostaglandin biosynthesis. Prostaglandins Leukot. Med. 1985; 19: 11-24.
34. Hertog MG, Kromhout D, Aravanis C. Flavonoids intake and long term risk of coronary heart disease and cancer in the seven countries study. Arch. Intern. Med. 1995; 155: 381-386.
35. Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem. Toxicol. 1995; 33: 1061-1080.
36. Hoult JR, Moroney MA, Paya M. Actions of flavonoids and coumarins on lipoxigenase and cyclooxygenase. Methods Enzymol. 1994; 234: 443-454.
37. Tordera M, Ferrandiz ML, Alcaraz MJ. Influence of anti-inflammatory flavonoids on degranulation and arachidonic acid release in rat neutrophils. Z. Naturforsch. 1994; 49: 235-240.